CSPC Pharmaceutical Group Ltd (CSPCY)
3.17
-0.05
(-1.55%)
USD |
OTCM |
Jun 21, 16:00
CSPC Pharmaceutical Group Gross Profit Margin (Quarterly): 70.99% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 70.99% |
September 30, 2023 | 71.35% |
June 30, 2023 | 71.25% |
March 31, 2023 | 68.53% |
Date | Value |
---|---|
December 31, 2022 | 69.53% |
September 30, 2022 | 72.84% |
June 30, 2022 | 71.45% |
March 31, 2022 | 73.80% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
68.53%
Minimum
Mar 2023
73.80%
Maximum
Mar 2022
71.22%
Average
71.30%
Median
Gross Profit Margin (Quarterly) Benchmarks
Sinovac Biotech Ltd | -- |
CASI Pharmaceuticals Inc | 52.98% |
Zai Lab Ltd | 61.42% |
Adagene Inc | -- |
LakeShore Biopharma Co Ltd | 81.92% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 18.27% |
Return on Assets | 13.40% |
Return on Invested Capital | 17.50% |
Profit Margin (Quarterly) | 18.18% |
Operating Margin (Quarterly) | 23.59% |
Return on Net Operating Assets | 17.72% |